SGH
PRXL

Sivik Global Healthcare’s Parexel International Corp PRXL Stock Holding History

Sivik Global Healthcare’s Portfolio PRXL Stock Details PRXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-35,000
Closed -$2.21M – 76
2017
Q1 		$2.21M Buy
35,000
+5,000
+17% +$331K 1.03% 38
2016
Q4 		$1.97M Buy
+30,000
New +$1.88M 0.94% 40
2016
Q1 		– Sell
-35,000
Closed -$2.38M – 71
2015
Q4 		$2.38M Buy
+35,000
New +$2.28M 1.13% 42

Other funds holding PRXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sivik Global Healthcare's PRXL Position: Q2 2017 in Review

Sivik Global Healthcare sold out of Parexel International Corp (PRXL) in Q2 2017, closing a stake of 35,000 shares — an estimated $2.21M sold.

Sivik Global Healthcare first reported a position in PRXL in Q4 2015 and held it in 3 quarters. The position peaked at $2.38M in Q4 2015. 311 funds tracked by Wall St. Rank hold PRXL as of Q2 2017.

  • Sivik Global Healthcare reported no remaining Parexel International Corp position as of Q2 2017 after selling out during the quarter.
  • Sivik Global Healthcare sold 35,000 Parexel International Corp shares in Q2 2017, an estimated $2.21M.
  • Sivik Global Healthcare first reported a position in Parexel International Corp in Q4 2015 and held it in 3 quarters.
  • Sivik Global Healthcare's Parexel International Corp position peaked at $2.38M in Q4 2015.
  • 311 funds tracked by Wall St. Rank held Parexel International Corp as of Q2 2017.

Based on Sivik Global Healthcare's 13F filing for Q2 2017, filed 11 Aug 2017.